Torrent Pharmaceuticals has fully redeemed and repaid the Secured Redeemable Non-Convertible Debentures (NCDs) of Rs 240 crore on March 24, 2020.
Torrent Pharmaceuticals is Flagship Company of the Torrent group, a leader in cardiovascular and central nervous system segments. It also has presence in gastro-intestinal, diabetology, anti-infective and pain management segments.